Showing 2301-2310 of 3810 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21836/Currents: PsO Many Options
https://practicaldermatology.com/topics/psoriasis/currents-pso-many-options/23211/Guidelines to Represent Your Dermatology Practice on Google My Business
https://practicaldermatology.com/topics/practice-management/guidelines-to-represent-your-dermatology-practice-on-google-my-business/20837/Google My Business is a powerful tool to reach out to and engage with your target audience online.Therapeutic Focus: Rosacea
https://practicaldermatology.com/topics/general-topics/therapeutic-focus-rosacea/21060/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21123/Psoriasis and the Metabolic Syndrome
https://practicaldermatology.com/topics/psoriasis/psoriasis-and-the-metabolic-syndrome/21535/Growing data support the notion that TNF inhibitors may decrease various risk factors for the metabolic syndrome.Combination approaches using Topical Vitamin D for Psoriasis
https://practicaldermatology.com/topics/psoriasis/combination-approaches-using-topical-vitamin-d-for-psoriasis/22920/A combination of topical vitamin D with some form of phototherapy and/or systemic therapy is a safe and effective option for plaque psoriasis.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21961/Dermatology Q&A: First Head-to-Head Data Highlight Safety and Efficacy of Biologics
https://practicaldermatology.com/topics/psoriasis/first-head-to-head-data-highlight-safety-and-efficacy-of-biologics/22032/A lead investigator on the first head-to-head trial of biologics shares insights on the future of biologic research and therapy.Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma
https://practicaldermatology.com/programs/cme/data-driving-recent-guideline-updates-in-neoadjuvant-therapy-for-resectable-melanoma/36322/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.